CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-28 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | −84,000 | $4.71 | $396K | 1,302,674 |
| 2023-12-28 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −19,000 | 1,283,674 | ||
| 2023-12-28 | Lowrance David L CHIEF FINANCIAL OFFICER | Sale | −10,000 | $4.71 | $47K | 342,355 |
| 2023-12-28 | Elam Nevan C Director | Option exercise | +1,758 | $0.82 | $1K | 64,343 |
| 2023-12-28 | Elam Nevan C Director | Option exercise | +12,000 | $1.59 | $19K | 76,343 |
| 2023-12-28 | Elam Nevan C Director | Option exercise | +40,000 | $1.23 | $49K | 116,343 |
| 2023-12-28 | Elam Nevan C Director | Sale | −93,843 | $4.71 | $442K | 22,500 |
| 2023-12-28 | Elam Nevan C Director | Option exercise · Stock Option (Right to Buy) | −1,758 | 0 | ||
| 2023-12-28 | Elam Nevan C Director | Option exercise · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2023-12-28 | Elam Nevan C Director | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-12-15 | Lowrance David L CHIEF FINANCIAL OFFICER | Gift | −20,000 | 352,355 | ||
| 2023-12-14 | Pratt Raymond Dennis Chief Medical Officer | Grant or award | +150,000 | 310,000 | ||
| 2023-12-14 | Pratt Raymond Dennis Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-12-14 | Lowrance David L CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −30,438 | $4.45 | $135K | 212,355 |
| 2023-12-14 | Lowrance David L CHIEF FINANCIAL OFFICER | Grant or award | +160,000 | 372,355 | ||
| 2023-12-14 | Lowrance David L CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-12-14 | Lutz Robert Matthew Chief Operating Officer | Grant or award | +160,000 | 300,000 | ||
| 2023-12-14 | Lutz Robert Matthew Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −109,680 | $4.45 | $488K | 936,674 |
| 2023-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Grant or award | +450,000 | 1,386,674 |
Page 6 of 11 · 202 trades